Design and evaluations of a nanostructured lipid carrier loaded with dopamine hydrochloride for intranasal bypass drug delivery in Parkinson’s disease

References

• Charalampos, T., et al., 2013. Severe nigrostriatal degeneration without clinical parkinsonism in patients with polymerase gamma mutations. Brain, 136, 2393–2404. doi: 10.1093/brain/awt103.
   PubMed Web of Science ®Google Scholar
• Cirri, M., et al., 2018. Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy. Drug delivery, 25 (1), 1910–1921. doi: 10.1080/10717544.2018.1529209.
   PubMed Web of Science ®Google Scholar
• Deepika, D., et al., 2019. Intranasal drug delivery of frovatriptan succinate loaded polymeric nanoparticles for brain targeting. Journal of pharmaceutical sciences, 108 (2), 851–859. doi: 10.1016/j.xphs.2018.07.013.
   PubMed Web of Science ®Google Scholar
• Dewangan, H.K., et al., 2018a. Hepatitis B antigen loaded biodegradable polymeric nanoparticles: formulation optimization and in-vivo immunization in BALB/c Mice. Current drug delivery, 15 (8), 1204–1215. doi: 10.2174/1567201815666180604110457.
   PubMed Web of Science ®Google Scholar
• Dewangan, H.K., et al., 2018b. Rational design and evaluation of HBsAg polymeric nanoparticles as antigen delivery carriers. International journal of biological macromolecules, 111, 804–812. doi: 10.1016/j.ijbiomac.2018.01.073.
   PubMed Web of Science ®Google Scholar
• Dewangan, H.K., et al., 2021. Mucoadhesive microspheres of atorvastatin calcium: rational design, evaluation and enhancement of bioavailability. Indian journal of pharmaceutical education and research, 55 (3s), S733–S741. doi: 10.5530/ijper.55.3s.180.
   Web of Science ®Google Scholar
• Dewangan, H.K., et al., 2022. Optimization and evaluation of Gymnema sylvestre (GYM) extract loaded polymeric nanoparticles for enhancement of in-vivo efficacy and reduction of toxicity. J. Microencapsul, 39 (2), 1–24.
   PubMed Web of Science ®Google Scholar
• Emami, J., et al., 2012. Formulation of LDL targeted nanostructured lipid carriers loaded with paclitaxel: a detailed study of preparation, freeze drying condition, and in vitro cytotoxicity. Journal of nanomaterials, 2012, 1–10. doi: 10.1155/2012/358782.
   Web of Science ®Google Scholar
• Ercument, K., et al., 2008. Permeation studies and histological examination of sheep nasal mucosa following administration of different nasal formulations with or without absorption enhancers. Drug delivery, 15 (4), 219–225. doi: 10.1080/10717540802006377.
   PubMed Web of Science ®Google Scholar
• Fahmy, U.A., et al., 2020. Optimized nanostructured lipid carriers integrated into in situ nasal gel for enhancing brain delivery of flibanserin. International journal of nanomedicine, 15, 5253–5264. doi: 10.2147/IJN.S258791.
   PubMed Web of Science ®Google Scholar
• Intakhab, A.M., et al., 2012. Intranasal administration of nanostructured lipid carriers containing CNS acting drug: pharmacodynamic studies and estimation in blood and brain. Journal of psychiatric research, 46, 1133–1138. doi: 10.1016/j.jpsychires.2012.05.014.
   PubMed Web of Science ®Google Scholar
• Jain, K., Sood, S., and Gowthamarajan, K., 2015. Optimization of artemether-loaded NLC for intranasal delivery using central composite design. Drug delivery, 22 (7), 940–954. doi: 10.3109/10717544.2014.885999.
   PubMed Web of Science ®Google Scholar
• Jason, R.C., et al., 2009. A highly reproducible rotenone model of Parkinson’s disease. Neurobiology of disease, 34, 279–290. doi: 10.1016/j.nbd.2009.01.016.
   PubMed Web of Science ®Google Scholar
• Lakshmi, L., Singh, S., Vijayakumar, M.R., Dewangan H.K. (2018), Lipid based aqueous core nanocapsules (ACNs) for encapsulating hydrophilic vinorelbine bitartrate: preparation, optimization, characterization and in vitro safety assessment for intravenous administration.Current drug delivery, 15 (9). 1284–1293. doi: 10.2174/1567201815666180716112457.
   PubMed Web of Science ®Google Scholar
• Mishra, A.K., et al., 2023. QbD assisted development and validation of UV spectroscopic method in estimation of silymarin. Lett. Drug des. Discov, 20, 1–13.
   Google Scholar
• Mishra, A.K., et al., 2023. Rationally designed nanoparticulate delivery approach for silymarin with natural bio-enhancer: in vitro characterization and in vivo evaluations of hepatoprotective effects in a mouse model. Journal of drug delivery science and technology, 86, 104580. doi: 10.1016/j.jddst.2023.104580.
   Web of Science ®Google Scholar
• Nehal, P.L., and Hitendra, M.S., 2018. Quercetin loaded nanostructured lipid carriers for nose to brain delivery: in vitro and in vivo studies. American journal of advanced drug delivery, 6 (01), 009–020.
   Google Scholar
• Omar, F.A.A., et al., 2021. Effects of bee venom and dopamine loaded nanoparticles on reserpine induced Parkinson’s disease rat model. Scientific reports, 11, 21141. doi: 10.1038/s41598-021-00764-y.
   PubMed Web of Science ®Google Scholar
• Omar, M., 2014. Studying the effect of dispersed drug crystal in the organic phase on the encapsulation by solvent evaporation technique; (4) dependent models as tools for studying the drug release. World J pharm sci, 2 (6), 549–564.
   Google Scholar
• Pardeshi, C.V., et al., 2013. Novale surface modified solid lipid nano particles as intranasal carriers for ropinirole hydrochloride: application of factorial design approach. Drug delivery, 20 (1), 47–56. doi: 10.3109/10717544.2012.752421.
   PubMed Web of Science ®Google Scholar
• Pinheiro, M., et al., 2016. Design of a nanostructured lipid carrier intended to improve the treatment of tuberculosis. Drug design, development and therapy, 10, 2467–2475. doi: 10.2147/DDDT.S104395.
   PubMed Web of Science ®Google Scholar
• Pintu, D.K., and Souvik, G., 2020. Formulation optimization, permeation kinetic and release mechanism study of in-situ nasal gel containing Ondansetron. Saudi J med pharm sci, 6 (1), 91–101. doi: 10.36348/sjmps.2020.v06i01.014.
   Google Scholar
• Praveen, S., et al., 2019. Ziprasidone hydrochloride loaded nanostructured lipid carriers (nlcs) for intranasal delivery: optimization and in vivo studies. International journal of applied pharmaceutics, 12 (1), 31–41. doi: 10.22159/ijap.2020v12i1.35683.
   Google Scholar
• Raghuvanshi, A., Shah, K., and Dewangan, H.K., 2022. Ethosome as antigen delivery carrier: optimization, evaluation and induction of immunological response via nasal route against hepatitis B. J. Microencapsul, 39 (4), 1–24.
   PubMed Web of Science ®Google Scholar
• Rashmin, P.B., et al., 2013. Formulation consideration and characterization of microemulsion drug delivery system for transnasal administration of carbamazepine. Bulletin facult pharmacy cairo univ, 51 (2), 243–253. doi: 10.1016/j.bfopcu.2013.07.002.
   Google Scholar
• Roberta, F., et al., 2019. Melatonin plus folic acid treatment ameliorates reserpine-induced fibromyalgia: an evaluation of pain. Oxidative stress, and inflammation, antioxidants, 8 (12), 628. doi: 10.3390/antiox8120628.
   Google Scholar
• Sharma, A.N., Upadhyay, P.K., and Dewangan, H.K., 2022. Development, evaluation, pharmacokinetic and biodistribution estimation of resveratrol-loaded solid lipid nanoparticles for prostate cancer targeting. Journal of microencapsulation, 39 (6), 563–574. doi: 10.1080/02652048.2022.2135785.
   PubMed Web of Science ®Google Scholar
• Sharma, S., Lohan, S., and Murthy, R.S.R., 2014. Formulation and characterization of intranasal mucoadhesive nanoparticulates and thermo-reversible gel of levodopa for brain delivery. Drug development and industrial pharmacy, 40 (7), 869–878. doi: 10.3109/03639045.2013.789051.
   PubMed Web of Science ®Google Scholar
• Sharma, V., et al., 2019. Rational design and in-vivo estimation of ivabradine hydrochloride loaded nanoparticles for management of stable angina. Journal of drug delivery science and technology, 54, 101337–101346. doi: 10.1016/j.jddst.2019.101337.
   Web of Science ®Google Scholar
• Singh, S., Shah, K., Dewangan, H. K., Lakshmi , Dual vinorelbine bitartrate and resveratrol loaded polymeric aqueous core nanocapsules for synergistic efficacy in breast cancer.Journal of microencapsulation, 39(4),. (2022) 299–313.
   PubMed Web of Science ®Google Scholar
• Singhvi, G., and Singh, M., 2011. Review: in-vitro drug release characterization models. International journal of pharmaceutical studies and research, 2 (1), 77–84.
   Google Scholar
• Sukala, M.P., Narayanan, S., and Muthusamy, R., 2017. Neurobehavioural changes in a hemiparkinsonian rat model induced by rotenone. Journal of clinical and diagnostic research, 11 (3), AF01–AF05. doi: 10.7860/JCDR/2017/24955.9604.
   Google Scholar
• Tomar, S., et al., 2022. A comprehensive review on carrier mediated nose to brain targeting: Emphasis on molecular targets, current trends, future prospects, and challenges. International journal of polymeric materials and polymeric biomaterials, 38, 1–13. doi: 10.1080/00914037.2022.2124255.
   Web of Science ®Google Scholar
• Tran, T.H., et al., 2014. Preparation and characterization of fenofibrate- loaded nanostructured Lipid carrier for oral bioavailability enhancement. American Association Pharmaceutical Scientists, 15 (6), 1509–1515. doi: 10.1208/s12249-014-0175-y.
   Web of Science ®Google Scholar
• Vandana, S.N., et al., 2014. Ameliorative Effect of Nebivolol in Parkinson’s disease. Erican journal of pharmacology and pharmacotherapeutics, 1 (3), 116–126.
   Google Scholar
• Vanshita, G.A., et al., 2023. Review: recent advances of nanotechnology in brain targeting. Current nanoscience, 19 (3), 350–361. doi: 10.2174/1573413718666220820113550.
   Web of Science ®Google Scholar
• Yadav, D., Semwal, B.C., and Dewangan, H.K., 2022. Grafting, characterization and enhancement of therapeutic activity of berberine loaded pegylated PAMAM dendrimer for cancerous cell. J. Biomater. Sci. Polym. Ed, 14, 1–14.
   Google Scholar
• Yadav, R.K., Shah, K., and Dewangan, H.K., 2022. Intranasal drug delivery of sumatriptan succinate loaded polymeric solid lipid nanoparticles for brain targeting. Drug development and industrial pharmacy. 15, 1–22.
   Google Scholar
• Zama, N.P.M., and Musa, M.V., 2019. Oleanolic acid mitigates 6-hydroxydopamine neurotoxicity by attenuating intracellular ROS in PC12 cells and striatal microglial activation in rat brains. Frontiers in physiology, 10, 1–10. doi: 10.3389/fphys.2019.01059.
   PubMed Web of Science ®Google Scholar
• Zhen-Nian, Z., et al., 2017. Subcutaneous rotenone rat model of Parkinson’s disease: dose exploration study. Brain research, 1655, 104–113. doi: 10.1016/j.brainres.2016.11.020.
   PubMed Web of Science ®Google Scholar